Antiplasmodial activity of [(aryl)arylsulfanylmethyl]pyridine

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 705-715

  Kumar, Sanjay ^a   Das, Sajal Kumar ^a   Dey, Sumanta ^b   Maity, Pallab ^b   Guha, Mithu ^b   Choubey, Vinay ^a   Panda, Gautam ^a   Bandyopadhyay, Uday ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

(SULFANYLMETHYL)PYRIDINE DERIVATIVE; ANTIMALARIAL AGENT; CHLOROQUINE; GLUTATHIONE; HEMATIN; HEMOZOIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LIPID PEROXIDE; MANNITOL; N TERT BUTYL ALPHA PHENYLNITRONE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CYTOTOXICITY; DRUG SELECTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PH MEASUREMENT; PLASMODIUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; BENZOIN; ERYTHROCYTES; HEMIN; HUMANS; MALARIA; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PYRIDINES;

EID: 38649134187     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00898-07     Document Type: Article

References (74)

1. Al-Qawasmeh, R. A., Y. Lee, M. Y. Cao, X. Gu, A. Vassilakos, J. A. Wright, and A. Young. 2004. Triaryl methane derivatives as antiproliferative agents. Bioorg. Med. Chem. Lett. 14:347-350.
2. Ancelin, M. L., H. J. Vial, and J. R. Philippot. 1985. Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro. Biochem. Pharmacol. 34:4068-4071.
3. Babbs, C. F., and M. G. Steiner. 1990. Detection and quantitation of hydroxyl radical using dimethyl sulfoxide as molecular probe. Methods Enzymol. 186:137-147.
4. Begriche, K., A. Igoudjil, D. Pessayre, and B. Fromenty. 2006. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6:1-28.
5. Biswas, K., U. Bandyopadhyay, I. Chattopadhyay, A. Varadaraj, E. Ali, and R. K. Banerjee. 2003. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. 278:10993-11001.
6. Bolshan, Y., C. Y. Chen, J. R. Chilenski, F. Gosselin, D. J. Mathre, P. D. O'Shea, A. Roy, and R. D. Tillyer. 2004. Nucleophilic displacement at benzhydryl centers: asymmetric synthesis of 1,1-diarylalkyl derivatives. Org. Lett. 6:111-114.
7. Brown, S. B., M. Shillcock, and P. Jones. 1976. Equilibrium and kinetic studies of the aggregation of porphyrins in aqueous solution. Biochem. J. 153:279-285.
8. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302-310.
9. Chattopadhyay, I., U. Bandyopadhyay, K. Biswas, P. Maity, and R. K. Banerjee. 2006. Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic. Biol. Med. 40:1397-1408.
10. Choubey, V., P. Maity, M. Guha, S. Kumar, K. Srivastava, S. K. Puri, and U. Bandyopadhyay. 2007. Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism. Antimicrob. Agents Chemother. 51:696-706.
11. Clark, I. A., and N. H. Hunt. 1983. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect. Immun. 39:1-6.
12. Coban, C., K. J. Ishii, D. J. Sullivan, and N. Kumar. 2002. Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect. Immun. 70:3939-3943.
13. Cossarizza, A., M. Baccarani-Contri, G. Kalashnikova, and C. Franceschi. 1993. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197:40-45.
14. Das, S. K., Shagufta, and G. Panda. 2005. An easy access to unsymmetric trisubstituted methane derivatives (TRSMs). Tetrahedron Lett. 46:3097-3102.
15. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
16. Egan, T. J. 2003. Haemozoin (malaria pigment): a unique crystalline drug target. Targets 2:115-124.
17. Egan, T. J. 2004. Haemozoin formation as a target for the rational design of new antimalarials. Drug Design Rev. 1:93-110.
18. Egan, T. J. 2002. Physico-chemical aspects of hemozoin (malaria pigment) structure and formation. J. Inorg. Biochem. 91:19-26.
19. Egan, T. J. 2001. Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials. Mini Rev. Med. Chem. 1:113-123.
20. Francis, S. E., D. J. Sullivan, Jr., and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
21. Friedman, M. J. 1979. Oxidant damage mediates variant red cell resistance to malaria. Nature 280:245-247.
22. Galli, U., L. Lazzarato, M. Bertinaria, G. Sorba, A. Gasco, S. Parapini, and D. Taramelli. 2005. Synthesis and antimalarial activities of some furoxan sulfones and related furazans. Eur. J. Med. Chem. 40:1335-1340.
23. Gemma, S., G. Campiani, S. Butini, G. Kukreja, B. P. Joshi, M. Persico, B. Catalanotti, E. Novellino, E. Fattorusso, V. Nacci, L. Savini, D. Taramelli, N. Basilico, G. Morace, V. Yardley, and C. Fattorusso. 2007. Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore. J. Med. Chem. 50:595-598.
24. Goldman, I. F., S. H. Qari, J. Skinner, S. Oliveira, J. M. Nascimento, M. M. Povoa, W. E. Collins, and A. A. Lal. 1992. Use of glass beads and CF 11 cellulose for removal of leukocytes from malaria-infected human blood in field settings. Mem. Inst. Oswaldo Cruz 87:583-587.
25. Greenwood, B., and T. Mutabingwa. 2002. Malaria in 2002. Nature 415:670-672.
26. Guha, M., S. Kumar, V. Choubey, P. Maity, and U. Bandyopadhyay. 2006. Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FASEB J. 20:1224-1226.
27. Jing, X. B., X. B. Cai, H. Hu, S. Z. Chen, B. M. Chen, and J. Y. Cai. 2007. Reactive oxygen species and mitochondrial membrane potential are modulated during CDDP-induced apoptosis in EC-109 cells. Biochem. Cell Biol. 85:265-271.
28. Kannan, R., K. Kumar, D. Sahal, S. Kukreti, and V. S. Chauhan. 2005. Reaction of artemisinin with haemoglobin: implications for antimalarial activity. Biochem. J. 385:409-418.
29. Kumar, S., and U. Bandyopadhyay. 2005. Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157:175-188.
30. Kumar, S., M. Guha, V. Choubey, P. Maity, and U. Bandyopadhyay. 2007. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life Sci. 80:813-828.
31. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
32. Lemberg, R., and J. Legge. 1949. Hematin compounds and bile pigments: their constitution, metabolism, and function. Interscience Publishers, New York, NY.
33. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
34. Mather, M. W., E. Darrouzet, M. Valkova-Valchanova, J. W. Cooley, M. T. McIntosh, F. Daldal, and A. B. Vaidya. 2005. Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system. J. Biol. Chem. 280:27458-27465.
35. McNally, J., S. M. O'Donovan, and J. P. Dalton. 1992. Plasmodium berghei and Plasmodium chabaudi chabaudi: development of simple in vitro erythrocyte invasion assays. Parasitology 105(Pt. 3):355-362.
36. Motterlini, R., R. Foresti, K. Vandegriff, M. Intaglietta, and R. M. Winslow. 1995. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am. J. Physiol. 269:H648-H655.
37. Munzel, T., I. B. Afanas'ev, A. L. Kleschyov, and D. G. Harrison. 2002. Detection of superoxide in vascular tissue. Arterioscler. Thromb. Vasc. Biol. 22:1761-1768.
38. Nair, V., S. Thomas, S. C. Mathew, and K. G. Abhilash. 2006. Recent advances in the chemistry of triaryl- and triheteroarylmethanes. Tetrahedron 62:6731-6747.
39. Novelli, F., B. Tasso, and F. Sparatore. 1999. Synthesis and pharmacological evaluation of some thiolupinine derivatives. Farmaco 54:354-358.
40. Orjih, A. U., H. S. Banyal, R. Chevli, and C. D. Fitch. 1981. Hemin lyses malaria parasites. Science 214:667-669.
41. Pagola, S., P. W. Stephens, D. S. Bohle, A. D. Kosar, and S. K. Madsen. 2000. The structure of malaria pigment beta-haematin. Nature 404:307-310.
42. Panda, G., J. K. Mishra, S. Sinha, A. K. Gaikwad, A. K. Srivastava, R. Srivastava, and B. S. Srivastava. 2005. 4-[10-(Methoxybenzyl)-9-anthryl-] phenol derivatives as new antitubercular agents. Arkivoc ii:29-45.
43. Panda, G., M. K. Parai, S. K. Das, Shagufta, M. Sinha, V. Chaturvedi, A. K. Srivastava, Y. S. Manju, A. N. Gaikwad, and S. Sinha. 2007. Effect of substituents on diarylmethanes for antitubercular activity. Eur. J. Med. Chem. 42:410-419.
44. Panda, G., Shagufta, J. K. Mishra, V. Chaturvedi, A. K. Srivastava, R. Srivastava, and B. S. Srivastava. 2004. Diaryloxy methano phenanthrenes: a new class of antituberculosis agents. Bioorg Med. Chem. 12:5269-5276.
45. Panda, G., Shagufta, A. K. Srivastava, and S. Sinha. 2005. Synthesis and antitubercular activity of 2-hydroxy-aminoalkyl derivatives of diaryloxy methano phenanthrenes. Bioorg Med. Chem. Lett. 15:5222-5225.
46. Pandey, A. V., N. Singh, B. L. Tekwani, S. K. Puri, and V. S. Chauhan. 1999. Assay of beta-hematin formation by malaria parasite. J. Pharm. Biomed Anal. 20:203-207.
47. Piccoli, C., R. Scrima, G. Quarato, A. D'Aprile, M. Ripoli, L. Lecce, D. Boffoli, D. Moradpour, and N. Capitanio. 2007. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46:58-65.
48. Portela, C., C. M. Afonso, M. M. Pinto, and M. J. Ramos. 2004. Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite. Bioorg Med. Chem. 12:3313-3321.
49. Rosenthal, P. J., and S. R. Meshnick. 1998. Hemoglobin processing and the metabolism of amino acids, heme and iron, p. 145-158. In I. W. Sherman (ed.), Malaria: parasite biology, pathogenesis and protection. ASM Press, Washington, DC.
50. Sachs, J., and P. Malaney. 2002. The economic and social burden of malaria. Nature 415:680-685.
51. Saliba, K. J., and K. Kirk. 1998. Clotrimazole inhibits the growth of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 92:666-667.
52. Santelli-Rouvier, C., B. Pradines, M. Berthelot, D. Parzy, and J. Barbe. 2004. Arylsulfonyl acridinyl derivatives acting on Plasmodium falciparum. Eur. J. Med. Chem. 39:735-744.
53. Schejter, A., A. Lanir, and N. Epstein. 1976. Binding of hydrogen donors to horseradish peroxidase: a spectroscopic study. Arch. Biochem. Biophys. 174:36-44.
54. Shagufta, A. Kumar, G. Panda, and M. I. Siddiqi. 2007. CoMFA and CoM-SIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents. J. Mol. Model. 13:99-109.
55. Shagufta, A. K. Srivastava, R. Sharma, R. Mishra, A. K. Balapure, P. S. Murthy, and G. Panda. 2006. Substituted phenanthrenes with basic amino side chains: a new series of anti-breast cancer agents. Bioorg Med. Chem. 14:1497-1505.
56. Solomon, V. R., S. K. Puri, K. Srivastava, and S. B. Katti. 2005. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Bioorg. Med. Chem. 13:2157-2165.
57. Srivastava, I. K., and A. B. Vaidya. 1999. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob. Agents Chemother. 43:1334-1339.
58. Srivastava, N., Sangita, S. Ray, M. M. Singh, A. Dwivedi, and A. Kumar. 2004. Diaryl naphthyl methanes, a novel class of anti-implantation agents. Bioorg. Med. Chem. 12:1011-1021.
59. Sullivan, D. J., Jr., I. Y. Gluzman, and D. E. Goldberg. 1996. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science 271:219- 222.
60. Tekwani, B. L., and L. A. Walker. 2005. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Comb. Chem. High Throughput Screen. 8:63-79.
61. Tiffert, T., H. Ginsburg, M. Krugliak, B. C. Elford, and V. L. Lew. 2000. Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 97:331-336.
62. Timur, M., S. H. Akbas, and T. Ozben. 2005. The effect of Topotecan on oxidative stress in MCF-7 human breast cancer cell line. Acta Biochim. Pol. 52:897-902.
63. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
64. Trivedi, V., P. Chand, P. R. Maulik, and U. Bandyopadhyay. 2005. Mechanism of horseradish peroxidase-catalyzed heme oxidation and polymerization (beta-hematin formation). Biochim. Biophys. Acta 1723:221-228.
65. Trivedi, V., P. Chand, K. Srivastava, S. K. Puri, P. R. Maulik, and U. Bandyopadhyay. 2005. Clotrimazole inhibits hemoperoxidase of Plasmodium falciparum and induces oxidative stress: proposed antimalarial mechanism of clotrimazole. J. Biol. Chem. 280:41129-41136.
66. Veldkamp, W. B., and J. R. Votano. 1976. Effects of intermolecular interaction on protein diffusion in solution. J. Phys. Chem. 80:2794-2801.
67. Vippagunta, S. R., A. Dorn, H. Matile, A. K. Bhattacharjee, J. M. Karle, W. Y. Ellis, R. G. Ridley, and J. L. Vennerstrom. 1999. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J. Med. Chem. 42:4630-4639.
68. Vlahakis, J. Z., R. T. Kinobe, K. Nakatsu, W. A. Szarek, and I. E. Crandall. 2006. Anti-Plasmodium activity of imidazole-dioxolane compounds. Bioorg. Med. Chem. Lett. 16:2396-2406.
69. Votano, J. R., M. Parham, L. H. Hall, and L. B. Kier. 2004. New predictors for several ADME/Tox properties: aqueous solubility, human oral absorption, and Ames genotoxicity using topological descriptors. Mol. Diversity 8:379-391.
70. Votano, Joseph, R., M. Parham, Lowell H. Hall, Lemont B. Kier, and L. M. Hall. 2004. Prediction of aqueous solubility based on large datasets using several QSPR models utilizing topological structure representation. Chem. Biodiversity 1:1829-1841.
71. White, N. J. 2004. Antimalarial drug resistance. J. Clin. Investig. 113:1084-1092.
72. World Health Organization 2000. WHO report: WHO Expert Committee on Malaria. W. H. O. Tech. Rep. Ser. 892:1-74.
73. Wozencraft, A. O., H. M. Dockrell, J. Taverne, G. A. Targett, and J. H. Playfair. 1984. Killing of human malaria parasites by macrophage secretory products. Infect. Immun. 43:664-669.
74. Zorov, D. B., C. R. Filburn, L. O. Klotz, J. L. Zweier, and S. J. Sollott. 2000. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192:1001-1014.